GF
SCMP

Gabelli Funds’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Gabelli Funds’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-301,015
Closed -$5.4M – 1178
2017
Q4 		$5.4M Buy
+301,015
New +$3.71M 0.03% 546

Other funds holding SCMP

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Gabelli Funds's SCMP Position: Q1 2018 in Review

Gabelli Funds sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 301,015 shares — an estimated $5.4M sold.

Gabelli Funds first reported a position in SCMP in Q4 2017 and held it in 1 quarter. The position peaked at $5.4M in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • Gabelli Funds reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • Gabelli Funds sold 301,015 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $5.4M.
  • Gabelli Funds first reported a position in Sucampo Pharmaceuticals, Inc. in Q4 2017 and held it in 1 quarter.
  • Gabelli Funds's Sucampo Pharmaceuticals, Inc. position peaked at $5.4M in Q4 2017.
  • 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Gabelli Funds's 13F filing for Q1 2018, filed 9 May 2018.